<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedWire News - Psoriasis via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MedWire News - Psoriasis' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=MedWire+News+-+Psoriasis&t=MedWire+News+-+Psoriasis&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 13:12:36 +0100</lastBuildDate>
        <item>
            <title>Psoriasis patients have increased VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5659855&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F97295%2FPsoriasis%2FPsoriasis_patients_have_increased_VTE_risk.html</link>
            <description>Results from a large study carried out in US women suggest that people with psoriasis have increased risk for venous thromboembolism. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659855</comments>
            <pubDate>Sun, 05 Feb 2012 17:27:56 +0100</pubDate>
            <guid isPermaLink="false">5659855</guid>        </item>
        <item>
            <title>ADAM33 gene variants associated with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=5638568&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F97164%2FPsoriasis%2FADAM33_gene_variants_associated_with_psoriasis.html</link>
            <description>Variants in a disintegrin and metalloproteinase 33 gene are associated with psoriasis in Han Chinese people, suggest study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638568</comments>
            <pubDate>Sun, 29 Jan 2012 17:40:17 +0100</pubDate>
            <guid isPermaLink="false">5638568</guid>        </item>
        <item>
            <title>Psoriasin potential target for psoriasis therapy</title>
            <link>http://www.medworm.com/index.php?rid=5608959&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F97018%2FPsoriasis%2FPsoriasin_potential_target_for_psoriasis_therapy.html</link>
            <description>Research suggests that blocking the formation of psoriasin, a protein that is abundant in the skin of psoriasis patients and thought to play a role in breast cancer progression, may help combat symptoms of the skin condition. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608959</comments>
            <pubDate>Fri, 20 Jan 2012 17:36:29 +0100</pubDate>
            <guid isPermaLink="false">5608959</guid>        </item>
        <item>
            <title>Psoriasis increases risk for coronary artery disease</title>
            <link>http://www.medworm.com/index.php?rid=5581955&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96880%2FPsoriasis%2FPsoriasis_increases_risk_for_coronary_artery_disease.html</link>
            <description>Patients with psoriasis undergoing coronary angiography have a higher prevalence of coronary artery disease than those without the condition, say researchers, particularly those with a long duration of the skin disease. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581955</comments>
            <pubDate>Fri, 13 Jan 2012 22:27:54 +0100</pubDate>
            <guid isPermaLink="false">5581955</guid>        </item>
        <item>
            <title>Psoriasis may increase the risk for diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5572251&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96725%2FPsoriasis%2FPsoriasis_may_increase_the_risk_for_diabetes.html</link>
            <description>Results from a systematic review and meta-analysis indicate that psoriasis is a risk factor for diabetes. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572251</comments>
            <pubDate>Sun, 08 Jan 2012 17:29:00 +0100</pubDate>
            <guid isPermaLink="false">5572251</guid>        </item>
        <item>
            <title>SNP typing accurately discriminates HLA-Cw*06:02 in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=5538074&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96583%2FPsoriasis%2FSNP_typing_accurately_discriminates_HLA-Cw0602_in_psoriasis_patients.html</link>
            <description>Researchers have developed a new technique for genotyping the main candidate gene HLA-C in patients with psoriasis, which allows discrimination of homozygotes and heterozygotes through typing of four single nucleotide polymorphisms. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538074</comments>
            <pubDate>Sun, 25 Dec 2011 06:05:18 +0100</pubDate>
            <guid isPermaLink="false">5538074</guid>        </item>
        <item>
            <title>Nail involvement in psoriasis increases risk for subclinical enthesopathy</title>
            <link>http://www.medworm.com/index.php?rid=5515497&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96452%2FPsoriasis%2FNail_involvement_in_psoriasis_increases_risk_for_subclinical_enthesopathy.html</link>
            <description>Patients with psoriasis involving the nails have increased risk for subclinical enthesopathy compared with healthy controls, report researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515497</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:07 +0100</pubDate>
            <guid isPermaLink="false">5515497</guid>        </item>
        <item>
            <title>Etanercept treatment for psoriasis may increase SCC risk</title>
            <link>http://www.medworm.com/index.php?rid=5486951&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96298%2FPsoriasis%2FEtanercept_treatment_for_psoriasis_may_increase_SCC_risk.html</link>
            <description>Etanercept treatment for psoriasis may be associated with an increased risk for multiple squamous cell carcinomas, suggest results from a case series and review of the literature. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486951</comments>
            <pubDate>Sat, 10 Dec 2011 06:10:51 +0100</pubDate>
            <guid isPermaLink="false">5486951</guid>        </item>
        <item>
            <title>Patient lifestyle impacts outcome importance of psoriasis treatment</title>
            <link>http://www.medworm.com/index.php?rid=5469081&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96169%2FPsoriasis%2FPatient_lifestyle_impacts_outcome_importance_of_psoriasis_treatment.html</link>
            <description>Patients with psoriasis tend to prefer treatments that fit in best with their personal and professional life, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469081</comments>
            <pubDate>Sun, 04 Dec 2011 06:07:03 +0100</pubDate>
            <guid isPermaLink="false">5469081</guid>        </item>
        <item>
            <title>Bacterial diversity altered in skin of psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=5441164&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F96030%2FPsoriasis%2FBacterial_diversity_altered_in_skin_of_psoriasis_patients.html</link>
            <description>Biopsies have revealed that the skin of patients with psoriasis show altered bacterial diversity compared with the skin of individuals without the condition. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5441164</comments>
            <pubDate>Fri, 25 Nov 2011 05:58:38 +0100</pubDate>
            <guid isPermaLink="false">5441164</guid>        </item>
        <item>
            <title>Differential psoriasis diagnosis required to exclude tinea corporis co-infection</title>
            <link>http://www.medworm.com/index.php?rid=5422248&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95878%2FPsoriasis%2FDifferential_psoriasis_diagnosis_required_to_exclude_tinea_corporis_co-infection.html</link>
            <description>Findings from a case report show that tinea corporis fungal infections can co-occur with generalized psoriasis vulgaris, showing a similar clinical appearance. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5422248</comments>
            <pubDate>Sat, 19 Nov 2011 05:53:09 +0100</pubDate>
            <guid isPermaLink="false">5422248</guid>        </item>
        <item>
            <title>Psoriasis patients at increased risk of diabetes and high blood pressure</title>
            <link>http://www.medworm.com/index.php?rid=5400842&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95724%2FPsoriasis%2FPsoriasis_patients_at_increased_risk_of_diabetes_and_high_blood_pressure.html</link>
            <description>Individuals with psoriasis are at an increased risk of developing diabetes and high blood pressure, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5400842</comments>
            <pubDate>Sun, 13 Nov 2011 05:50:11 +0100</pubDate>
            <guid isPermaLink="false">5400842</guid>        </item>
        <item>
            <title>Indigo naturalis shows potential for treating nail psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=5386937&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95590%2FPsoriasis%2FIndigo_naturalis_shows_potential_for_treating_nail_psoriasis.html</link>
            <description>Results from a pilot study suggest that topical application of indigo naturalis ointment, extracted from the leaves of indigo-bearing plants such as Baphicacanthus cusia and Polygonum tinctorium, may improve the symptoms of nail psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5386937</comments>
            <pubDate>Thu, 10 Nov 2011 07:12:59 +0100</pubDate>
            <guid isPermaLink="false">5386937</guid>        </item>
        <item>
            <title>Psoriasis may increase the risk for erectile dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=5360486&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95461%2FPsoriasis%2FPsoriasis_may_increase_the_risk_for_erectile_dysfunction.html</link>
            <description>Study results suggest that having a history of psoriasis may increase the risk for erectile dysfunction. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5360486</comments>
            <pubDate>Mon, 31 Oct 2011 03:56:13 +0100</pubDate>
            <guid isPermaLink="false">5360486</guid>        </item>
        <item>
            <title>Comorbidities influence patient preference for psoriasis treatments</title>
            <link>http://www.medworm.com/index.php?rid=5336005&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95327%2FPsoriasis%2FComorbidities_influence_patient_preference_for_psoriasis_treatments.html</link>
            <description>Patient comorbidities should be taken into account when choosing suitable treatments for psoriasis, say researchers, as they can significantly influence treatment preferences. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336005</comments>
            <pubDate>Sat, 22 Oct 2011 04:59:21 +0100</pubDate>
            <guid isPermaLink="false">5336005</guid>        </item>
        <item>
            <title>Psoriasis common side effect of IBD therapy in women</title>
            <link>http://www.medworm.com/index.php?rid=5314613&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95197%2FPsoriasis%2FPsoriasis_common_side_effect_of_IBD_therapy_in_women.html</link>
            <description>Psoriasiform lesions are a common side effect of anti-tumor necrosis factor antibody treatment for inflammatory bowel disease particularly in women, show study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314613</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:10 +0100</pubDate>
            <guid isPermaLink="false">5314613</guid>        </item>
        <item>
            <title>Smoking reduces risk for psoriatic arthritis in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=5297080&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F95054%2FPsoriasis%2FSmoking_reduces_risk_for_psoriatic_arthritis_in_psoriasis_patients.html</link>
            <description>Smoking may reduce the risk for psoriatic arthritis in patients with psoriasis, say researchers, but not in patients who are positive for the human leukocyte antigen allele HLA-C*06. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297080</comments>
            <pubDate>Sun, 09 Oct 2011 05:29:08 +0100</pubDate>
            <guid isPermaLink="false">5297080</guid>        </item>
        <item>
            <title>Psoriasis associated with variety of medical comorbidities</title>
            <link>http://www.medworm.com/index.php?rid=5273991&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94919%2FPsoriasis%2FPsoriasis_associated_with_variety_of_medical_comorbidities.html</link>
            <description>Psoriasis patients have an increased risk for a number of medical comorbidities, show study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273991</comments>
            <pubDate>Mon, 03 Oct 2011 05:07:20 +0100</pubDate>
            <guid isPermaLink="false">5273991</guid>        </item>
        <item>
            <title>Psoriasis increases risk for poor pregnancy outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5250844&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94786%2FPsoriasis%2FPsoriasis_increases_risk_for_poor_pregnancy_outcomes.html</link>
            <description>Women with psoriasis are at increased risk for having a preterm birth and low-birth-weight infants compared with those without the condition, suggest study findings. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5250844</comments>
            <pubDate>Sun, 25 Sep 2011 17:44:07 +0100</pubDate>
            <guid isPermaLink="false">5250844</guid>        </item>
        <item>
            <title>Dermatologists prefer UVB as first-line for psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=5225726&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94624%2FPsoriasis%2FDermatologists_prefer_UVB_as_first-line_for_psoriasis.html</link>
            <description>Dermatologists’ preferred choice of first-line therapy for patients with psoriasis is ultraviolet B treatment, report US researchers in the Journal of the American Academy of Dermatology. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5225726</comments>
            <pubDate>Sun, 18 Sep 2011 01:35:19 +0100</pubDate>
            <guid isPermaLink="false">5225726</guid>        </item>
        <item>
            <title>Online follow-up is effective for psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=5208996&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94511%2FPsoriasis%2FOnline_follow-up_is_effective_for_psoriasis_patients.html</link>
            <description>Study results show that an online follow-up system for individuals with psoriasis is just as effective as standard in-office follow-up. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5208996</comments>
            <pubDate>Mon, 12 Sep 2011 21:21:13 +0100</pubDate>
            <guid isPermaLink="false">5208996</guid>        </item>
        <item>
            <title>Algorithm for psoriasis treatment in elderly</title>
            <link>http://www.medworm.com/index.php?rid=5184151&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94344%2FPsoriasis%2FAlgorithm_for_psoriasis_treatment_in_elderly.html</link>
            <description>A new treatment algorithm, developed by the Medical Board of the National Psoriasis Foundation, outlines several therapeutic options for elderly patients with psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5184151</comments>
            <pubDate>Sat, 03 Sep 2011 15:03:19 +0100</pubDate>
            <guid isPermaLink="false">5184151</guid>        </item>
        <item>
            <title>Genetic markers for PsA identified</title>
            <link>http://www.medworm.com/index.php?rid=5208997&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94503%2FPsoriasis%2FGenetic_markers_for_PsA_identified.html</link>
            <description>Canadian research results confirm a previous association between a human leukocyte antigen risk allele and psoriatic arthritis and identify several further potential genetic markers for the condition among patients with psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5208997</comments>
            <pubDate>Fri, 02 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5208997</guid>        </item>
        <item>
            <title>Psoriasis biologics do not increase major cardiovascular risk</title>
            <link>http://www.medworm.com/index.php?rid=5161897&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94206%2FPsoriasis%2FPsoriasis_biologics_do_not_increase_major_cardiovascular_risk.html</link>
            <description>Results of a meta-analysis of randomized-controlled trials show that the risk for major adverse cardiovascular events is not increased in psoriasis patients treated with anti-interleukin 12/23, or anti-tumor necrosis factor α agents. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161897</comments>
            <pubDate>Sat, 27 Aug 2011 15:05:18 +0100</pubDate>
            <guid isPermaLink="false">5161897</guid>        </item>
        <item>
            <title>Psoriasis patients at risk for AF and stroke</title>
            <link>http://www.medworm.com/index.php?rid=5144035&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F94076%2FPsoriasis%2FPsoriasis_patients_at_risk_for_AF_and_stroke.html</link>
            <description>Individuals with psoriasis are at increased risk for developing atrial fibrillation and ischemic stroke compared with those in the general population, show Danish study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5144035</comments>
            <pubDate>Sat, 20 Aug 2011 15:44:29 +0100</pubDate>
            <guid isPermaLink="false">5144035</guid>        </item>
        <item>
            <title>Possible link between psoriasis and CVD risk factors</title>
            <link>http://www.medworm.com/index.php?rid=5119956&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93944%2FPsoriasis%2FPossible_link_between_psoriasis_and_CVD_risk_factors.html</link>
            <description>Patients with psoriasis are more likely than those with dermatitis to develop risk factors for cardiovascular disease, report researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5119956</comments>
            <pubDate>Fri, 12 Aug 2011 16:59:26 +0100</pubDate>
            <guid isPermaLink="false">5119956</guid>        </item>
        <item>
            <title>Majority of psoriasis patients want involvement in treatment decisions</title>
            <link>http://www.medworm.com/index.php?rid=5097949&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93828%2FPsoriasis%2FMajority_of_psoriasis_patients_want_involvement_in_treatment_decisions.html</link>
            <description>Study results show that the majority of patients with psoriasis would prefer to be involved in making decisions about their treatment. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5097949</comments>
            <pubDate>Sat, 06 Aug 2011 15:50:29 +0100</pubDate>
            <guid isPermaLink="false">5097949</guid>        </item>
        <item>
            <title>Psoriatic arthritis patients lack vitamin D</title>
            <link>http://www.medworm.com/index.php?rid=5052869&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93474%2FPsoriasis%2FPsoriatic_arthritis_patients_lack_vitamin_D.html</link>
            <description>There is a high prevalence of vitamin D insufficiency and deficiency among people with psoriatic arthritis, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5052869</comments>
            <pubDate>Sat, 23 Jul 2011 16:21:48 +0100</pubDate>
            <guid isPermaLink="false">5052869</guid>        </item>
        <item>
            <title>Weight loss could improve psoriasis outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5030507&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93338%2FPsoriasis%2FWeight_loss_could_improve_psoriasis_outcomes.html</link>
            <description>US researchers report that weight loss could play a potential role in the treatment of psoriasis after they observed a dramatic improvement in the condition of two patients who underwent gastric bypass surgery. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5030507</comments>
            <pubDate>Sat, 16 Jul 2011 16:19:41 +0100</pubDate>
            <guid isPermaLink="false">5030507</guid>        </item>
        <item>
            <title>Psoriatic arthritis predicts psoriasis severity</title>
            <link>http://www.medworm.com/index.php?rid=5010000&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93255%2FPsoriasis%2FPsoriatic_arthritis_predicts_psoriasis_severity.html</link>
            <description>Researchers have shown a clear link between psoriasis and arthritis severity in patients with psoriatic arthritis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5010000</comments>
            <pubDate>Sat, 09 Jul 2011 19:06:33 +0100</pubDate>
            <guid isPermaLink="false">5010000</guid>        </item>
        <item>
            <title>Psoriasis patients at increased risk for hospitalization for infectious disease</title>
            <link>http://www.medworm.com/index.php?rid=4986284&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F93042%2FPsoriasis%2FPsoriasis_patients_at_increased_risk_for_hospitalization_for_infectious_disease.html</link>
            <description>Patients with psoriasis are almost twice as likely as individuals in the general population to be hospitalized for an infectious disease, report Dutch researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4986284</comments>
            <pubDate>Fri, 01 Jul 2011 17:13:49 +0100</pubDate>
            <guid isPermaLink="false">4986284</guid>        </item>
        <item>
            <title>Alcohol misuse high in moderate to severe psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4970473&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92959%2FPsoriasis%2FAlcohol_misuse_high_in_moderate_to_severe_psoriasis_patients.html</link>
            <description>Patients with moderate to severe psoriasis have high rates of alcohol misuse, say Irish and UK researchers who recommend the screening of psoriasis patients to allow appropriate interventions. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4970473</comments>
            <pubDate>Mon, 27 Jun 2011 18:06:40 +0100</pubDate>
            <guid isPermaLink="false">4970473</guid>        </item>
        <item>
            <title>Adalimumab improves productivity among psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4937075&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92833%2FPsoriasis%2FAdalimumab_improves_productivity_among_psoriasis_patients.html</link>
            <description>Study results show that treatment with adalimumab can significantly reduce work productivity and activity impairment in patients with moderate to severe psoriasis, compared with placebo. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4937075</comments>
            <pubDate>Sat, 18 Jun 2011 16:31:30 +0100</pubDate>
            <guid isPermaLink="false">4937075</guid>        </item>
        <item>
            <title>Previous psoriasis worsens cancer prognosis</title>
            <link>http://www.medworm.com/index.php?rid=4923318&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92714%2FPsoriasis%2FPrevious_psoriasis_worsens_cancer_prognosis.html</link>
            <description>Patients with cancer have a worse prognosis – indicated by a greater cancer-specific and overall mortality excess – if they have previously had psoriasis, compared with those who have not had the skin condition, show Swedish study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4923318</comments>
            <pubDate>Mon, 13 Jun 2011 16:04:39 +0100</pubDate>
            <guid isPermaLink="false">4923318</guid>        </item>
        <item>
            <title>Psoriasis pathology may inhibit melanogenesis</title>
            <link>http://www.medworm.com/index.php?rid=4895422&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92575%2FPsoriasis%2FPsoriasis_pathology_may_inhibit_melanogenesis_.html</link>
            <description>Individuals with psoriasis have significantly less melanocytic nevi compared with people without the skin condition, report Italian researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4895422</comments>
            <pubDate>Sun, 05 Jun 2011 18:38:26 +0100</pubDate>
            <guid isPermaLink="false">4895422</guid>        </item>
        <item>
            <title>Dead Sea climatotherapy more effective for early-onset psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4873328&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92437%2FPsoriasis%2FDead_Sea_climatotherapy_more_effective_for_early-onset_psoriasis.html</link>
            <description>Dead Sea climatotherapy is not only highly effective for treatment of plaque psoriasis, but has the greatest effect on early- versus late-onset forms of the disease, report researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4873328</comments>
            <pubDate>Sat, 28 May 2011 17:12:58 +0100</pubDate>
            <guid isPermaLink="false">4873328</guid>        </item>
        <item>
            <title>Psoriatic arthritis may be more common than previously reported</title>
            <link>http://www.medworm.com/index.php?rid=4842939&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92310%2FPsoriasis%2FPsoriatic_arthritis_may_be_more_common_than_previously_reported.html</link>
            <description>There may be a higher incidence of psoriatic arthritis among patients with moderate-to-severe psoriasis than has been previously reported, show the results of Canadian research. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4842939</comments>
            <pubDate>Fri, 20 May 2011 15:52:47 +0100</pubDate>
            <guid isPermaLink="false">4842939</guid>        </item>
        <item>
            <title>Anti-TNF-α psoriasis treatment is inefficacious over time</title>
            <link>http://www.medworm.com/index.php?rid=4822119&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92144%2FPsoriasis%2FAnti-TNF-%CE%B1_psoriasis_treatment_is_inefficacious_over_time.html</link>
            <description>The overall efficacy of tumor necrosis factor-α inhibitors for the treatment of psoriasis diminishes with time, as indicated by the progressive loss of patient adherence to the treatment, say Danish researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822119</comments>
            <pubDate>Sat, 14 May 2011 18:09:58 +0100</pubDate>
            <guid isPermaLink="false">4822119</guid>        </item>
        <item>
            <title>NPF issues treatment recommendations for psoriasis in elderly</title>
            <link>http://www.medworm.com/index.php?rid=4795308&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F92090%2FPsoriasis%2FNPF_issues_treatment_recommendations_for_psoriasis_in_elderly.html</link>
            <description>Elderly individuals with limited psoriasis should be treated topically while those with more extensive disease should receive phototherapy or biologics with appropriate monitoring, recommends the Medical Board of the US National Psoriasis Foundation. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4795308</comments>
            <pubDate>Sat, 07 May 2011 16:55:07 +0100</pubDate>
            <guid isPermaLink="false">4795308</guid>        </item>
        <item>
            <title>Extreme psoriasis increases mortality risk, not through CVD</title>
            <link>http://www.medworm.com/index.php?rid=4763754&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91985%2FPsoriasis%2FExtreme_psoriasis_increases_mortality_risk%2C_not_through_CVD.html</link>
            <description>Patients with “exceptionally severe” psoriasis have an increased mortality risk compared with those with less extreme forms of the condition, but as a result of diseases other than cardiovascular disease, report researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4763754</comments>
            <pubDate>Fri, 29 Apr 2011 19:40:07 +0100</pubDate>
            <guid isPermaLink="false">4763754</guid>        </item>
        <item>
            <title>Psoriasis increases cancer risk in Taiwanese young men</title>
            <link>http://www.medworm.com/index.php?rid=4736216&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91954%2FPsoriasis%2FPsoriasis_increases_cancer_risk_in_Taiwanese_young_men.html</link>
            <description>Individuals with psoriasis are at increased risk for developing a malignancy compared with the general population, Taiwanese study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4736216</comments>
            <pubDate>Fri, 22 Apr 2011 16:15:28 +0100</pubDate>
            <guid isPermaLink="false">4736216</guid>        </item>
        <item>
            <title>Psoriasis varies considerably according to age, gender, race in minors</title>
            <link>http://www.medworm.com/index.php?rid=4720253&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91903%2FPsoriasis%2FPsoriasis_varies_considerably_according_to_age%2C_gender%2C_race_in_minors.html</link>
            <description>Study findings indicate that although prevalence of psoriasis among children and adolescents in California is low, it varies considerably according to age, gender, and race. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4720253</comments>
            <pubDate>Sat, 16 Apr 2011 16:51:11 +0100</pubDate>
            <guid isPermaLink="false">4720253</guid>        </item>
        <item>
            <title>Psoriasis makes hypertension harder to control</title>
            <link>http://www.medworm.com/index.php?rid=4686546&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91806%2FPsoriasis%2FPsoriasis_makes_hypertension_harder_to_control.html</link>
            <description>Study results show that hypertension is less easily controlled in patients who also have psoriasis compared with non-psoriatic hypertensive patients. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4686546</comments>
            <pubDate>Fri, 08 Apr 2011 16:04:26 +0100</pubDate>
            <guid isPermaLink="false">4686546</guid>        </item>
        <item>
            <title>Systemic inflammation associated with atherosclerosis in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4665056&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91692%2FPsoriasis%2FSystemic_inflammation_associated_with_atherosclerosis_in_psoriasis_patients.html</link>
            <description>Young patients with psoriasis have significantly increased arterial thickness, but no difference in vascular endothelial dysfunction compared with age- and gender-matched controls, show study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4665056</comments>
            <pubDate>Fri, 01 Apr 2011 17:37:05 +0100</pubDate>
            <guid isPermaLink="false">4665056</guid>        </item>
        <item>
            <title>Low psoriatic arthritis prevalence in Asian patients, but much is undiagnosed</title>
            <link>http://www.medworm.com/index.php?rid=4637040&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91619%2FPsoriasis%2FLow_psoriatic_arthritis_prevalence_in_Asian_patients%2C_but_much_is_undiagnosed.html</link>
            <description>Study results confirm a low prevalence of psoriatic arthritis among psoriasis patients in Asia, however, they also reveal a high percentage of undiagnosed cases among patients under specialist care. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4637040</comments>
            <pubDate>Sat, 26 Mar 2011 16:56:27 +0100</pubDate>
            <guid isPermaLink="false">4637040</guid>        </item>
        <item>
            <title>Increased risk for acute MI in Asian psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4611508&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91535%2FPsoriasis%2FIncreased_risk_for_acute_MI_in_Asian_psoriasis_patients.html</link>
            <description>Asian patients with psoriasis may have an increased risk for acute myocardial infarction, report Taiwanese researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611508</comments>
            <pubDate>Sat, 19 Mar 2011 16:30:50 +0100</pubDate>
            <guid isPermaLink="false">4611508</guid>        </item>
        <item>
            <title>Good patient-doctor relationship key to management of psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4571663&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91429%2FPsoriasis%2FGood_patient-doctor_relationship_key_to_management_of_psoriasis.html</link>
            <description>The latest guideline in a series published by the American Academy of Dermatology suggests that patient education and the fostering of a good patient-doctor relationship is essential to optimize psoriasis treatment. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4571663</comments>
            <pubDate>Fri, 11 Mar 2011 16:35:24 +0100</pubDate>
            <guid isPermaLink="false">4571663</guid>        </item>
        <item>
            <title>Comorbidities significantly increase economic burden of psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4550282&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91356%2FPsoriasis%2FComorbidities_significantly_increase_economic_burden_of_psoriasis.html</link>
            <description>Patients with psoriasis and comorbidities incur significantly more health costs, mostly as a result of greater utilization of medical services, compared with psoriasis patients without comorbidities, research results show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4550282</comments>
            <pubDate>Sat, 05 Mar 2011 16:55:12 +0100</pubDate>
            <guid isPermaLink="false">4550282</guid>        </item>
        <item>
            <title>Start dose for UV-B psoriasis treatment important for tolerance, not efficacy</title>
            <link>http://www.medworm.com/index.php?rid=4522851&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91276%2FPsoriasis%2FStart_dose_for_UV-B_psoriasis_treatment_important_for_tolerance%2C_not_efficacy.html</link>
            <description>Determining the appropriate dose of narrowband ultraviolet-B treatment for psoriasis patients by first working out their minimal erythemal dose does not affect treatment efficacy, but is important for identifying adverse effects, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522851</comments>
            <pubDate>Sat, 26 Feb 2011 16:32:19 +0100</pubDate>
            <guid isPermaLink="false">4522851</guid>        </item>
        <item>
            <title>Adalimumbab effective for psoriasis previously treated with anti-TNF therapy</title>
            <link>http://www.medworm.com/index.php?rid=4496014&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91187%2FPsoriasis%2FAdalimumbab_effective_for_psoriasis_previously_treated_with_anti-TNF_therapy.html</link>
            <description>Patients with chronic plaque psoriasis can be treated effectively with adalimumab even if treatment with other anti-tumor necrosis factor agents has failed, shows a subanalysis of the BELIEVE study. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496014</comments>
            <pubDate>Sat, 19 Feb 2011 17:13:10 +0100</pubDate>
            <guid isPermaLink="false">4496014</guid>        </item>
        <item>
            <title>Systemic therapy could reduce CV risk in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4465686&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91104%2FPsoriasis%2FSystemic_therapy_could_reduce_CV_risk_in_psoriasis_patients.html</link>
            <description>Patients with severe plaque-type psoriasis who respond well to continuous systemic therapy experience a simultaneous reduction in levels of biomarkers that indicate cardiovascular risk, show study findings. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4465686</comments>
            <pubDate>Sat, 12 Feb 2011 16:30:01 +0100</pubDate>
            <guid isPermaLink="false">4465686</guid>        </item>
        <item>
            <title>Etanercept effective with favorable safety profile for psoriasis over 4 years</title>
            <link>http://www.medworm.com/index.php?rid=4437080&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F91029%2FPsoriasis%2FEtanercept_effective_with_favorable_safety_profile_for_psoriasis_over_4_years.html</link>
            <description>Pooled results from four studies show that etanercept is an effective treatment for psoriasis for up to 4 years, with low rates of serious adverse events. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4437080</comments>
            <pubDate>Sat, 05 Feb 2011 16:27:00 +0100</pubDate>
            <guid isPermaLink="false">4437080</guid>        </item>
        <item>
            <title>Presence of arthritis does not affect osteoporosis in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4412359&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90942%2FPsoriasis%2FPresence_of_arthritis_does_not_affect_osteoporosis_in_psoriasis_patients.html</link>
            <description>Psoriasis patients are at increased risk for osteoporosis, based on serum osteoprotegrin elevations, regardless of whether they have psoriatic arthritis, say Egyptian researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4412359</comments>
            <pubDate>Sat, 29 Jan 2011 15:19:17 +0100</pubDate>
            <guid isPermaLink="false">4412359</guid>        </item>
        <item>
            <title>Nonlight beer intake associated with psoriasis risk in women</title>
            <link>http://www.medworm.com/index.php?rid=4383453&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90853%2FPsoriasis%2FNonlight_beer_intake_associated_with_psoriasis_risk_in_women.html</link>
            <description>Women who drink five or more nonlight beers per week have an increased risk for developing psoriasis compared with women who do not drink alcohol, study findings indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383453</comments>
            <pubDate>Sat, 22 Jan 2011 15:31:43 +0100</pubDate>
            <guid isPermaLink="false">4383453</guid>        </item>
        <item>
            <title>Metabolic syndrome risk increased in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=4350311&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90771%2FPsoriasis%2FMetabolic_syndrome_risk_increased_in_psoriasis_patients.html</link>
            <description>Patients with psoriasis are almost twice as likely to have the metabolic syndrome as people in the general population, study findings indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4350311</comments>
            <pubDate>Sat, 15 Jan 2011 15:47:24 +0100</pubDate>
            <guid isPermaLink="false">4350311</guid>        </item>
        <item>
            <title>Adalimumab effective for hand and foot psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4322972&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90693%2FPsoriasis%2FAdalimumab_effective_for_hand_and_foot_psoriasis.html</link>
            <description>Adalimumab is an effective and well tolerated treatment for chronic plaque psoriasis of the hands and feet, report researchers who found efficacy was maintained for at least 28 weeks. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4322972</comments>
            <pubDate>Sat, 08 Jan 2011 11:39:33 +0100</pubDate>
            <guid isPermaLink="false">4322972</guid>        </item>
        <item>
            <title>Dermoscopy useful for distinguishing psoriasis from seborrheic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=4301030&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90615%2FPsoriasis%2FDermoscopy_useful_for_distinguishing_psoriasis_from_seborrheic_dermatitis.html</link>
            <description>Scalp psoriasis and seborrheic dermatitis can be differentiated by looking at vascular patterns using dermoscopy, report researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301030</comments>
            <pubDate>Fri, 31 Dec 2010 23:51:07 +0100</pubDate>
            <guid isPermaLink="false">4301030</guid>        </item>
        <item>
            <title>Psoriasis ‘not independent CVD risk factor’</title>
            <link>http://www.medworm.com/index.php?rid=4301031&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90549%2FPsoriasis%2FPsoriasis_%E2%80%98not_independent_CVD_risk_factor%E2%80%99.html</link>
            <description>Patients with moderate-to-severe psoriasis without cardiovascular disease or its traditional risk factors have normal endothelial function, a UK study shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301031</comments>
            <pubDate>Fri, 31 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4301031</guid>        </item>
        <item>
            <title>Methotrexate, cyclosporine ‘moderately effective’ psoriatic nail treatments</title>
            <link>http://www.medworm.com/index.php?rid=4267580&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90524%2FPsoriasis%2FMethotrexate%2C_cyclosporine_%E2%80%98moderately_effective%E2%80%99_psoriatic_nail_treatments.html</link>
            <description>Methotrexate and cyclosporine are both moderately effective at treating psoriatic nails, research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4267580</comments>
            <pubDate>Sun, 19 Dec 2010 17:01:21 +0100</pubDate>
            <guid isPermaLink="false">4267580</guid>        </item>
        <item>
            <title>IFIH1 variant protects against psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4249728&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90430%2FPsoriasis%2FIFIH1_variant_protects_against_psoriasis.html</link>
            <description>Researchers have identified a rare missense variant in the gene encoding the putative RNA helicase interferon induced with helicase C domain 1 that may help protect against psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4249728</comments>
            <pubDate>Sat, 11 Dec 2010 16:02:32 +0100</pubDate>
            <guid isPermaLink="false">4249728</guid>        </item>
        <item>
            <title>Adalimumab shows superior benefit-risk profile for  psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4226455&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90335%2FPsoriasis%2FAdalimumab_shows_superior_benefit-risk_profile_for__psoriasis.html</link>
            <description>Adalimumab has a superior benefit-risk profile to that of methotrexate, analysis of data from the CHAMPION trial shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4226455</comments>
            <pubDate>Sat, 04 Dec 2010 01:04:12 +0100</pubDate>
            <guid isPermaLink="false">4226455</guid>        </item>
        <item>
            <title>Clinical and genetic factors affect NB-UVB clearance, remission</title>
            <link>http://www.medworm.com/index.php?rid=4201111&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90249%2FPsoriasis%2FClinical_and_genetic_factors_affect_NB-UVB_clearance%2C_remission.html</link>
            <description>Both genetic and clinical parameters are important in determining the number of exposures of narrow-band ultraviolet B needed to clear psoriasis and the duration of remission, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4201111</comments>
            <pubDate>Fri, 26 Nov 2010 04:23:49 +0100</pubDate>
            <guid isPermaLink="false">4201111</guid>        </item>
        <item>
            <title>NB-UVB irradiation achieved long-term psoriasis remission</title>
            <link>http://www.medworm.com/index.php?rid=4184196&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90142%2FPsoriasis%2FNB-UVB_irradiation_achieved_long-term_psoriasis_remission.html</link>
            <description>Narrowband ultraviolet B light irradiation 5 days a week for 4 weeks is an effective treatment option for psoriasis vulgaris, say researchers who found it induced long-term remission. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4184196</comments>
            <pubDate>Sat, 20 Nov 2010 05:18:08 +0100</pubDate>
            <guid isPermaLink="false">4184196</guid>        </item>
        <item>
            <title>Severe maternal psoriasis increases low birthweight infant risk</title>
            <link>http://www.medworm.com/index.php?rid=4156149&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F90017%2FPsoriasis%2FSevere_maternal_psoriasis_increases_low_birthweight_infant_risk.html</link>
            <description>Women with severe psoriasis appear to have an increased risk for having low birthweight babies, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4156149</comments>
            <pubDate>Fri, 12 Nov 2010 04:26:31 +0100</pubDate>
            <guid isPermaLink="false">4156149</guid>        </item>
        <item>
            <title>New genetic susceptibility loci for psoriasis identified</title>
            <link>http://www.medworm.com/index.php?rid=4110117&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89854%2FPsoriasis%2FNew_genetic_susceptibility_loci_for_psoriasis_identified.html</link>
            <description>Researchers have found new psoriasis susceptibility loci that could aid diagnosis of the condition and the development of new treatments. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4110117</comments>
            <pubDate>Fri, 29 Oct 2010 17:36:11 +0100</pubDate>
            <guid isPermaLink="false">4110117</guid>        </item>
        <item>
            <title>MED selection of NB–UV-B starting dose does not impair efficacy</title>
            <link>http://www.medworm.com/index.php?rid=4089797&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89768%2FPsoriasis%2FMED_selection_of_NB%E2%80%93UV-B_starting_dose_does_not_impair_efficacy.html</link>
            <description>Basing the starting dose of narrowband ultraviolet-B treatment for chronic psoriasis on minimal erythemal dose does not reduce treatment efficacy compared with a standard fixed starting dose, researchers have found. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4089797</comments>
            <pubDate>Sun, 24 Oct 2010 01:17:59 +0100</pubDate>
            <guid isPermaLink="false">4089797</guid>        </item>
        <item>
            <title>Erectile dysfunction common in patients with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4068550&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89679%2FPsoriasis%2FErectile_dysfunction_common_in_patients_with_psoriasis.html</link>
            <description>Erectile dysfunction appears to be common in patients with psoriasis and may be partly due to incipient atherosclerosis, pilot study finding suggest. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4068550</comments>
            <pubDate>Sat, 16 Oct 2010 08:40:46 +0100</pubDate>
            <guid isPermaLink="false">4068550</guid>        </item>
        <item>
            <title>Composite score gauges psoriasis, PsA treatment success</title>
            <link>http://www.medworm.com/index.php?rid=4046507&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89586%2FPsoriasis%2FComposite_score_gauges_psoriasis%2C_PsA_treatment_success.html</link>
            <description>A composite measure to quantify the effects of treatment for psoriasis and psoriatic arthritis on skin symptoms, joint manifestations, and quality of life may be useful to determine the overall success of treatment, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4046507</comments>
            <pubDate>Sun, 10 Oct 2010 00:40:00 +0100</pubDate>
            <guid isPermaLink="false">4046507</guid>        </item>
        <item>
            <title>Pruritus self-assessment tool valid in moderate to severe psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=4024060&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89493%2FPsoriasis%2FPruritus_self-assessment_tool_valid_in_moderate_to_severe_psoriasis.html</link>
            <description>A simple patient-reported pruritus assessment tool is reliable and reflects treatment-related improvements in patients with moderate to severe psoriasis, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4024060</comments>
            <pubDate>Sat, 02 Oct 2010 18:43:30 +0100</pubDate>
            <guid isPermaLink="false">4024060</guid>        </item>
        <item>
            <title>Dead Sea salt bath boosts UVB benefits in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3999659&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89387%2FPsoriasis%2FDead_Sea_salt_bath_boosts_UVB_benefits_in_psoriasis.html</link>
            <description>Patients with psoriasis undergoing phototherapy achieve larger improvements in their condition if they simultaneously bathe in a Dead Sea salt solution, shows a randomized trial. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3999659</comments>
            <pubDate>Sat, 25 Sep 2010 07:27:46 +0100</pubDate>
            <guid isPermaLink="false">3999659</guid>        </item>
        <item>
            <title>Infliximab reduces nail psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3978228&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89297%2FPsoriasis%2FInfliximab_reduces_nail_psoriasis.html</link>
            <description>Infliximab is effective for reducing nail lesions in patients with psoriasis, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3978228</comments>
            <pubDate>Sat, 18 Sep 2010 05:57:06 +0100</pubDate>
            <guid isPermaLink="false">3978228</guid>        </item>
        <item>
            <title>Serious mental illnesses increased in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3948100&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89195%2FPsoriasis%2FSerious_mental_illnesses_increased_in_psoriasis_patients.html</link>
            <description>Patients with psoriasis have an increased risk for clinical depression, anxiety, and suicidal behavior, including ideation and attempt, compared with the general population, study findings indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948100</comments>
            <pubDate>Fri, 10 Sep 2010 07:11:05 +0100</pubDate>
            <guid isPermaLink="false">3948100</guid>        </item>
        <item>
            <title>NB–UV-B improves vitamin D status in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3930202&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89117%2FPsoriasis%2FNB%E2%80%93UV-B_improves_vitamin_D_status_in_psoriasis_patients.html</link>
            <description>Narrowband ultraviolet-B treatment appears to increase serum levels of 25-hydroxyvitamin D as well as clear psoriasis, research suggests, with the number of exposures determining the magnitude of increase. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3930202</comments>
            <pubDate>Sat, 04 Sep 2010 05:41:39 +0100</pubDate>
            <guid isPermaLink="false">3930202</guid>        </item>
        <item>
            <title>Psoriasis patients’ QoL impacts healthcare use independent of disease severity</title>
            <link>http://www.medworm.com/index.php?rid=3908936&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F89026%2FPsoriasis%2FPsoriasis_patients%E2%80%99_QoL_impacts_healthcare_use_independent_of_disease_severity.html</link>
            <description>Poor quality of life in patients with psoriasis is associated with greater use of healthcare resources and employment disadvantages independently of disease severity, research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3908936</comments>
            <pubDate>Sat, 28 Aug 2010 05:43:09 +0100</pubDate>
            <guid isPermaLink="false">3908936</guid>        </item>
        <item>
            <title>Adalimumab efficacy consistent across different patient subgroups</title>
            <link>http://www.medworm.com/index.php?rid=3886750&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88952%2FPsoriasis%2FAdalimumab_efficacy_consistent_across_different_patient_subgroups.html</link>
            <description>The efficacy of adalimumab to provide at least a 75% improvement in Psoriasis Area and Severity Index score appears to be consistently strong across different subgroups of patients, subanalyses of the REVEAL study show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3886750</comments>
            <pubDate>Sat, 21 Aug 2010 05:46:01 +0100</pubDate>
            <guid isPermaLink="false">3886750</guid>        </item>
        <item>
            <title>Serum prolactin levels correlate with psoriasis activity</title>
            <link>http://www.medworm.com/index.php?rid=3863178&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88863%2FPsoriasis%2FSerum_prolactin_levels_correlate_with_psoriasis_activity.html</link>
            <description>Serum prolactin levels may be a useful biological marker of psoriatic activity, say Spanish researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3863178</comments>
            <pubDate>Sat, 14 Aug 2010 05:38:48 +0100</pubDate>
            <guid isPermaLink="false">3863178</guid>        </item>
        <item>
            <title>Psoriasis patients need better education to self-manage effectively</title>
            <link>http://www.medworm.com/index.php?rid=3828994&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88774%2FPsoriasis%2FPsoriasis_patients_need_better_education_to_self-manage_effectively.html</link>
            <description>More systematic educational interventions are needed for patients with mild-to-moderate psoriasis in order for them to effectively self-manage their condition, UK research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3828994</comments>
            <pubDate>Sat, 07 Aug 2010 05:30:43 +0100</pubDate>
            <guid isPermaLink="false">3828994</guid>        </item>
        <item>
            <title>Characteristics of pediatric psoriasis outlined</title>
            <link>http://www.medworm.com/index.php?rid=3803730&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88686%2FPsoriasis%2FCharacteristics_of_pediatric_psoriasis_outlined.html</link>
            <description>Children with psoriasis usually present with mild disease, predominantly of the plaque type, and boys are primarily affected, indicate the results of a Greek epidemiological study. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3803730</comments>
            <pubDate>Sat, 31 Jul 2010 05:31:36 +0100</pubDate>
            <guid isPermaLink="false">3803730</guid>        </item>
        <item>
            <title>Traumatic experiences linked to psoriasis onset</title>
            <link>http://www.medworm.com/index.php?rid=3755517&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88486%2FPsoriasis%2FTraumatic_experiences_linked_to_psoriasis_onset.html</link>
            <description>Research suggests that the likelihood of developing psoriasis is increased in people who have experienced negative traumatic experiences during childhood or adulthood. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3755517</comments>
            <pubDate>Fri, 16 Jul 2010 05:30:29 +0100</pubDate>
            <guid isPermaLink="false">3755517</guid>        </item>
        <item>
            <title>Anti-infliximab antibody status related to psoriasis clinical response</title>
            <link>http://www.medworm.com/index.php?rid=3738571&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88384%2FPsoriasis%2FAnti-infliximab_antibody_status_related_to_psoriasis_clinical_response.html</link>
            <description>Measuring antibodies to infliximab in patients with psoriasis may be an important clinical strategy for avoiding or delaying loss of response to the drug, study findings suggest. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3738571</comments>
            <pubDate>Sat, 10 Jul 2010 05:27:36 +0100</pubDate>
            <guid isPermaLink="false">3738571</guid>        </item>
        <item>
            <title>Homocysteine status liked to CVD in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3715632&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88255%2FPsoriasis%2FHomocysteine_status_liked_to_CVD_in_psoriasis_patients.html</link>
            <description>Patients with psoriasis may have significantly raised levels of homocysteine, which could contribute to the increased prevalence of cardiovascular disease in these patients, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3715632</comments>
            <pubDate>Fri, 02 Jul 2010 05:28:46 +0100</pubDate>
            <guid isPermaLink="false">3715632</guid>        </item>
        <item>
            <title>Topical treatment gives early boost to adalimumab efficacy</title>
            <link>http://www.medworm.com/index.php?rid=3697089&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88171%2FPsoriasis%2FTopical_treatment_gives_early_boost_to_adalimumab_efficacy.html</link>
            <description>The addition of calcipotriol/betamethasone topical ointment to the biologic adalimumab appears to be associated with higher efficacy for treating moderate-to-severe psoriasis than adalimumab alone, but it may not persist long term, research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3697089</comments>
            <pubDate>Sat, 26 Jun 2010 05:27:42 +0100</pubDate>
            <guid isPermaLink="false">3697089</guid>        </item>
        <item>
            <title>Clinical course of guttate psoriasis generally good</title>
            <link>http://www.medworm.com/index.php?rid=3673565&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F88066%2FPsoriasis%2FClinical_course_of_guttate_psoriasis_generally_good.html</link>
            <description>Study results indicate that guttate psoriasis tends to have a better prognosis than other types of psoriasis, but researchers warn that progression of the guttate form of psoriasis into the chronic plaque form is not uncommon. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3673565</comments>
            <pubDate>Sat, 19 Jun 2010 05:27:38 +0100</pubDate>
            <guid isPermaLink="false">3673565</guid>        </item>
        <item>
            <title>Adalimumab may reduce depressive symptoms in patients with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3653762&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87963%2FPsoriasis%2FAdalimumab_may_reduce_depressive_symptoms_in_patients_with_psoriasis.html</link>
            <description>Adalimumab treatment may reduce depression as well as skin symptoms in patients with psoriasis, thereby improving health-related quality of life, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3653762</comments>
            <pubDate>Sat, 12 Jun 2010 13:04:52 +0100</pubDate>
            <guid isPermaLink="false">3653762</guid>        </item>
        <item>
            <title>Adalimumab effective following an unsatisfactory etanercept response</title>
            <link>http://www.medworm.com/index.php?rid=3632947&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87877%2FPsoriasis%2FAdalimumab_effective_following_an_unsatisfactory_etanercept_response.html</link>
            <description>Adalimumab is an effective treatment option for patients with plaque psoriasis who have not shown an adequate response or have lost their response to etanercept after a dose decrease, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3632947</comments>
            <pubDate>Sun, 06 Jun 2010 13:02:03 +0100</pubDate>
            <guid isPermaLink="false">3632947</guid>        </item>
        <item>
            <title>Ustekinumab improves depression, anxiety in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3608704&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87797%2FPsoriasis%2FUstekinumab_improves_depression%2C_anxiety_in_psoriasis_patients.html</link>
            <description>Ustekinumab improves symptoms of anxiety, depression, and skin-related quality of life in patients with psoriasis, US study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3608704</comments>
            <pubDate>Sat, 29 May 2010 13:02:04 +0100</pubDate>
            <guid isPermaLink="false">3608704</guid>        </item>
        <item>
            <title>Biologics may be cost effective long term in high-need psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3587154&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87704%2FPsoriasis%2FBiologics_may_be_cost_effective_long_term_in_high-need_psoriasis_patients.html</link>
            <description>The high costs of biologic therapies may be off-set by reducing long hospitalizations in high-need psoriasis patients, shows a study comparing direct costs before and after biologics were introduced. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3587154</comments>
            <pubDate>Sat, 22 May 2010 13:03:06 +0100</pubDate>
            <guid isPermaLink="false">3587154</guid>        </item>
        <item>
            <title>TNF antagonists have favorable benefit-risk profile for psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3564950&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87616%2FPsoriasis%2FTNF_antagonists_have_favorable_benefit-risk_profile_for_psoriasis.html</link>
            <description>Tumor necrosis factor antagonists are more likely to be successful for the treatment of psoriasis during the initial year of treatment than they are to cause serious toxicity, quantitative benefit-risk assessment data show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3564950</comments>
            <pubDate>Sat, 15 May 2010 13:01:21 +0100</pubDate>
            <guid isPermaLink="false">3564950</guid>        </item>
        <item>
            <title>Psoriasis linked to hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=3544001&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87526%2FPsoriasis%2FPsoriasis_linked_to_hepatitis_C.html</link>
            <description>Patients with psoriasis are at increased risk for hepatitis C, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3544001</comments>
            <pubDate>Sat, 08 May 2010 13:02:00 +0100</pubDate>
            <guid isPermaLink="false">3544001</guid>        </item>
        <item>
            <title>Family history and psoriasis severity predict psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=3500019&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87364%2FPsoriasis%2FFamily_history_and_psoriasis_severity_predict_psoriatic_arthritis.html</link>
            <description>Psoriasis patients are at greater risk for psoriatic arthritis if they have a family history of psoriatic arthritis and a greater maximum body surface area affected by psoriasis, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3500019</comments>
            <pubDate>Sat, 24 Apr 2010 13:17:00 +0100</pubDate>
            <guid isPermaLink="false">3500019</guid>        </item>
        <item>
            <title>Severe psoriasis increases cardiovascular mortality risk</title>
            <link>http://www.medworm.com/index.php?rid=3477104&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87254%2FPsoriasis%2FSevere_psoriasis_increases_cardiovascular_mortality_risk.html</link>
            <description>Patients with severe psoriasis have an increased risk for mortality due to cardiovascular (CV) disease, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3477104</comments>
            <pubDate>Sat, 17 Apr 2010 13:03:55 +0100</pubDate>
            <guid isPermaLink="false">3477104</guid>        </item>
        <item>
            <title>Childhood-onset psoriasis does not influence disease severity</title>
            <link>http://www.medworm.com/index.php?rid=3455347&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87171%2FPsoriasis%2FChildhood-onset_psoriasis_does_not_influence_disease_severity.html</link>
            <description>The age at which people develop psoriasis does not appear to have a big impact on the subsequent course of the disease, study findings indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3455347</comments>
            <pubDate>Sat, 10 Apr 2010 13:05:09 +0100</pubDate>
            <guid isPermaLink="false">3455347</guid>        </item>
        <item>
            <title>Safety of topical corticosteroids in pregnancy remains undecided</title>
            <link>http://www.medworm.com/index.php?rid=3430657&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87084%2FPsoriasis%2FSafety_of_topical_corticosteroids_in_pregnancy_remains_undecided.html</link>
            <description>The current evidence concerning the safety of topical corticosteroids in pregnancy is limited and inconclusive, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3430657</comments>
            <pubDate>Fri, 02 Apr 2010 13:04:13 +0100</pubDate>
            <guid isPermaLink="false">3430657</guid>        </item>
        <item>
            <title>Psoriasis may increase pregnancy complications</title>
            <link>http://www.medworm.com/index.php?rid=3409447&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F87006%2FPsoriasis%2FPsoriasis_may_increase_pregnancy_complications.html</link>
            <description>Pregnant women with psoriasis may be at increased risk for complications, including spontaneous abortion, preterm birth, pre-eclampsia, placenta previa, and ectopic pregnancy, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409447</comments>
            <pubDate>Sat, 27 Mar 2010 14:04:02 +0100</pubDate>
            <guid isPermaLink="false">3409447</guid>        </item>
        <item>
            <title>Psychopathology heightened in psoriasis compared with atopic dermatitis</title>
            <link>http://www.medworm.com/index.php?rid=3384110&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86917%2FPsoriasis%2FPsychopathology_heightened_in_psoriasis_compared_with_atopic_dermatitis.html</link>
            <description>Patients with psoriasis appear to have a worse psychosocial reaction to their condition than patients with atopic dermatitis, say researchers who suggest this may be due to a direct central nervous system affect, aside from the impact of increased stigma. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3384110</comments>
            <pubDate>Sat, 20 Mar 2010 14:03:58 +0100</pubDate>
            <guid isPermaLink="false">3384110</guid>        </item>
        <item>
            <title>Antibodies to adalimumab affect treatment response in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=3336556&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86705%2FPsoriasis%2FAntibodies_to_adalimumab_affect_treatment_response_in_psoriasis_patients.html</link>
            <description>Some patients who take adalimumab for the treatment of plaque psoriasis develop antibodies to the drug, which could impair their responses to the treatment, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3336556</comments>
            <pubDate>Sat, 06 Mar 2010 14:03:41 +0100</pubDate>
            <guid isPermaLink="false">3336556</guid>        </item>
        <item>
            <title>Far erythemogenic NB-UVB dose effective for plaque-type psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3312919&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86607%2FPsoriasis%2FFar_erythemogenic_NB-UVB_dose_effective_for_plaque-type_psoriasis.html</link>
            <description>Far erythemogenic dose of narrow-band ultraviolet B phototherapy appears to be as effective as near and suberythemogenic doses for plaque-type psoriasis, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3312919</comments>
            <pubDate>Sat, 27 Feb 2010 14:04:05 +0100</pubDate>
            <guid isPermaLink="false">3312919</guid>        </item>
        <item>
            <title>Psoriasis linked to psychiatric morbidity and cardiovascular risk factors</title>
            <link>http://www.medworm.com/index.php?rid=3289185&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86522%2FPsoriasis%2FPsoriasis_linked_to_psychiatric_morbidity_and_cardiovascular_risk_factors.html</link>
            <description>Psoriasis appears to be independently associated with significant psychiatric comorbidities and with adverse cardiovascular risk factors, but not cardiovascular events, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3289185</comments>
            <pubDate>Sat, 20 Feb 2010 14:04:36 +0100</pubDate>
            <guid isPermaLink="false">3289185</guid>        </item>
        <item>
            <title>Twice, rather than once, weekly etanercept offers skin but not joint benefits</title>
            <link>http://www.medworm.com/index.php?rid=3264112&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86383%2FPsoriasis%2FTwice%2C_rather_than_once%2C_weekly_etanercept_offers_skin_but_not_joint_benefits.html</link>
            <description>Twice weekly treatment with 50 mg of etanercept appears to be superior to once weekly treatment for the clearance of skin lesions in patients with psoriasis and psoriatic arthritis, findings from the PRESTA study show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3264112</comments>
            <pubDate>Fri, 12 Feb 2010 14:03:32 +0100</pubDate>
            <guid isPermaLink="false">3264112</guid>        </item>
        <item>
            <title>Methotrexate enhances NBUVB treatment of psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3245216&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86350%2FPsoriasis%2FMethotrexate_enhances_NBUVB_treatment_of_psoriasis.html</link>
            <description>The combination of methotrexate and narrowband ultraviolet B phototherapy may offer psoriasis patients more rapid clinical improvement of their symptoms than narrowband ultraviolet B phototherapy alone, research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3245216</comments>
            <pubDate>Sat, 06 Feb 2010 14:09:57 +0100</pubDate>
            <guid isPermaLink="false">3245216</guid>        </item>
        <item>
            <title>No increased cancer risk with coal tar treatment</title>
            <link>http://www.medworm.com/index.php?rid=3221715&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86244%2FPsoriasis%2FNo_increased_cancer_risk_with_coal_tar_treatment.html</link>
            <description>Researchers say that coal tar for the treatment of psoriasis and eczema should not be abandoned, after finding concerns of an associated increased risk for cancer are unfounded. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3221715</comments>
            <pubDate>Sat, 30 Jan 2010 14:00:23 +0100</pubDate>
            <guid isPermaLink="false">3221715</guid>        </item>
        <item>
            <title>Rising psoriasis treatment costs outstrip inflation</title>
            <link>http://www.medworm.com/index.php?rid=3199130&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86151%2FPsoriasis%2FRising_psoriasis_treatment_costs_outstrip_inflation.html</link>
            <description>The cost of systemic therapies for psoriasis in the USA appears to be increasing at a faster rate than inflation, cost model findings suggest. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199130</comments>
            <pubDate>Sat, 23 Jan 2010 14:00:35 +0100</pubDate>
            <guid isPermaLink="false">3199130</guid>        </item>
        <item>
            <title>Ustekinumab shows superior efficacy in moderate-to-severe psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3177188&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F86050%2FPsoriasis%2FUstekinumab_shows_superior_efficacy_in_moderate-to-severe_psoriasis.html</link>
            <description>Ustekinumab appears to more effective than etanercept for the treatment of moderate-to-severe psoriasis, with a similar safety profile, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3177188</comments>
            <pubDate>Sat, 16 Jan 2010 14:00:44 +0100</pubDate>
            <guid isPermaLink="false">3177188</guid>        </item>
        <item>
            <title>CRP proposed as marker for psoriasis severity</title>
            <link>http://www.medworm.com/index.php?rid=3154456&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85958%2FPsoriasis%2FCRP_proposed_as_marker_for_psoriasis_severity.html</link>
            <description>C-reactive protein appears to be a useful marker of psoriasis severity, say researchers who believe it could be used to monitor the disease and its treatment. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154456</comments>
            <pubDate>Sat, 09 Jan 2010 14:01:53 +0100</pubDate>
            <guid isPermaLink="false">3154456</guid>        </item>
        <item>
            <title>Smoking and alcohol intake linked to severe psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=3134405&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85857%2FPsoriasis%2FSmoking_and_alcohol_intake_linked_to_severe_psoriasis.html</link>
            <description>Smoking and alcohol intake are independently associated with severe forms of psoriasis, confirm researchers (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3134405</comments>
            <pubDate>Fri, 01 Jan 2010 13:59:08 +0100</pubDate>
            <guid isPermaLink="false">3134405</guid>        </item>
        <item>
            <title>Pediatric psoriasis increases with increasing age</title>
            <link>http://www.medworm.com/index.php?rid=3119624&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85854%2FPsoriasis%2FPediatric_psoriasis_increases_with_increasing_age.html</link>
            <description>The incidence of pediatric psoriasis has increased over recent years, say researchers whose study also refutes the hypothesis that there is a dual peak in psoriasis incidence. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3119624</comments>
            <pubDate>Fri, 25 Dec 2009 13:59:40 +0100</pubDate>
            <guid isPermaLink="false">3119624</guid>        </item>
        <item>
            <title>Adalimumab reduces  psoriatic arthritis as well as psoriasis symptoms</title>
            <link>http://www.medworm.com/index.php?rid=3097884&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85756%2FPsoriasis%2FAdalimumab_reduces__psoriatic_arthritis_as_well_as_psoriasis_symptoms.html</link>
            <description>Psoriasis patients taking adalimumab for the treatment of moderate-to-severe psoriasis may also experience a reduction in comorbid psoriatic arthritis symptoms, research suggests. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3097884</comments>
            <pubDate>Fri, 18 Dec 2009 14:02:24 +0100</pubDate>
            <guid isPermaLink="false">3097884</guid>        </item>
        <item>
            <title>Childhood psoriasis common and a significant burden</title>
            <link>http://www.medworm.com/index.php?rid=3058014&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85577%2FPsoriasis%2FChildhood_psoriasis_common_and_a_significant_burden.html</link>
            <description>Psoriasis is common and associated with significant comorbidity in children, researchers have found. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3058014</comments>
            <pubDate>Sat, 05 Dec 2009 13:59:34 +0100</pubDate>
            <guid isPermaLink="false">3058014</guid>        </item>
        <item>
            <title>Psoriasis patients at increased risk for subclinical atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=3035021&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85474%2FPsoriasis%2FPsoriasis_patients_at_increased_risk_for_subclinical_atherosclerosis.html</link>
            <description>Researchers have found further evidence to support a link between psoriasis and subclinical atherosclerosis in patients without clinically evident cardiovascular disease or other cardiovascular risk factors. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3035021</comments>
            <pubDate>Sat, 28 Nov 2009 14:02:36 +0100</pubDate>
            <guid isPermaLink="false">3035021</guid>        </item>
        <item>
            <title>Psoriasis treatment guidelines proposed for patients with concomitant HCV</title>
            <link>http://www.medworm.com/index.php?rid=2990495&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85251%2FPsoriasis%2FPsoriasis_treatment_guidelines_proposed_for_patients_with_concomitant_HCV.html</link>
            <description>Topical therapy and ultraviolet B phototherapy should be considered first-line and second-line therapies for patients with limited psoriasis and concomitant hepatitis C virus infection, suggests a consensus report from the Medical Board of the US National Psoriasis Foundation. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2990495</comments>
            <pubDate>Sat, 14 Nov 2009 14:03:31 +0100</pubDate>
            <guid isPermaLink="false">2990495</guid>        </item>
        <item>
            <title>Psoriasis not independently linked to ischemic heart disease</title>
            <link>http://www.medworm.com/index.php?rid=2968683&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F85148%2FPsoriasis%2FPsoriasis_not_independently_linked_to_ischemic_heart_disease.html</link>
            <description>Psoriasis may not be a clinical risk factor for ischemic heart disease hospitalization, Dutch study findings suggest. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2968683</comments>
            <pubDate>Sat, 07 Nov 2009 13:59:13 +0100</pubDate>
            <guid isPermaLink="false">2968683</guid>        </item>
        <item>
            <title>Metabolic syndrome risk high in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=2921635&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84936%2FPsoriasis%2FMetabolic_syndrome_risk_high_in_psoriasis_patients.html</link>
            <description>The metabolic syndrome affects more than half of patients with psoriasis, with the likelihood of the syndrome increasing with the severity of the skin condition, delegates were told at the 18th Congress of the European Academy of Dermatology and Venereology in Berlin, Germany. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921635</comments>
            <pubDate>Sat, 24 Oct 2009 12:59:38 +0100</pubDate>
            <guid isPermaLink="false">2921635</guid>        </item>
        <item>
            <title>Placebo-controlled trial supports PUVA’s efficacy in plaque-type psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2900298&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84848%2FPsoriasis%2FPlacebo-controlled_trial_supports_PUVA%E2%80%99s_efficacy_in_plaque-type_psoriasis.html</link>
            <description>Psoralen plus ultraviolet A is a highly efficacious treatment for patients with chronic plaque psoriasis, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2900298</comments>
            <pubDate>Sat, 17 Oct 2009 12:57:52 +0100</pubDate>
            <guid isPermaLink="false">2900298</guid>        </item>
        <item>
            <title>UVB treatment appears a feasible option for children with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2877562&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84749%2FPsoriasis%2FUVB_treatment_appears_a_feasible_option_for_children_with_psoriasis.html</link>
            <description>Narrowband ultraviolet B phototherapy is a valid resource in the treatment of children with psoriasis, say Spanish researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877562</comments>
            <pubDate>Sat, 10 Oct 2009 16:40:50 +0100</pubDate>
            <guid isPermaLink="false">2877562</guid>        </item>
        <item>
            <title>Topical psoralen enhances UVB efficacy in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2853363&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84656%2FPsoriasis%2FTopical_psoralen_enhances_UVB_efficacy_in_psoriasis.html</link>
            <description>Topical application of 8-methoxypsoralen gel increases the efficacy of narrowband ultraviolet B therapy in patients with psoriasis, Turkish study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2853363</comments>
            <pubDate>Fri, 02 Oct 2009 16:28:28 +0100</pubDate>
            <guid isPermaLink="false">2853363</guid>        </item>
        <item>
            <title>Symptom frequency needs to be considered when evaluating psoriasis severity</title>
            <link>http://www.medworm.com/index.php?rid=2833197&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84560%2FPsoriasis%2FSymptom_frequency_needs_to_be_considered_when_evaluating_psoriasis_severity.html</link>
            <description>Researchers have called for the development of new scoring systems for evaluating psoriasis severity that incorporate the symptoms of the disease. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833197</comments>
            <pubDate>Sat, 26 Sep 2009 16:25:34 +0100</pubDate>
            <guid isPermaLink="false">2833197</guid>        </item>
        <item>
            <title>BMI linked to psoriasis onset and severity</title>
            <link>http://www.medworm.com/index.php?rid=2808699&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84478%2FPsoriasis%2FBMI_linked_to_psoriasis_onset_and_severity.html</link>
            <description>Excessive body weight increases both the risk for psoriasis onset and the severity of the condition, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2808699</comments>
            <pubDate>Sat, 19 Sep 2009 16:22:10 +0100</pubDate>
            <guid isPermaLink="false">2808699</guid>        </item>
        <item>
            <title>Responses to facial expressions of disgust diminished in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=2787211&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84372%2FPsoriasis%2FResponses_to_facial_expressions_of_disgust_diminished_in_psoriasis_patients.html</link>
            <description>Patients with psoriasis appear to develop coping mechanisms to protect them from stressful emotional responses elicited by people’s facial expressions of disgust, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2787211</comments>
            <pubDate>Sat, 12 Sep 2009 16:21:04 +0100</pubDate>
            <guid isPermaLink="false">2787211</guid>        </item>
        <item>
            <title>TNF inhibitors more effective than T-cell agents in treating plaque psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2769429&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84264%2FPsoriasis%2FTNF_inhibitors_more_effective_than_T-cell_agents_in_treating_plaque_psoriasis.html</link>
            <description>Tumor necrosis factor inhibitors are more effective than T-cell agents for the treatment of moderate-to-severe plaque psoriasis, results of a systematic review and meta analysis indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2769429</comments>
            <pubDate>Sun, 06 Sep 2009 16:21:36 +0100</pubDate>
            <guid isPermaLink="false">2769429</guid>        </item>
        <item>
            <title>Efalizumab effective for psoriasis after failed TNF blocker therapy</title>
            <link>http://www.medworm.com/index.php?rid=2742580&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84145%2FPsoriasis%2FEfalizumab_effective_for_psoriasis_after_failed_TNF_blocker_therapy.html</link>
            <description>Efalizumab can be used to treat psoriasis in patients who have either failed to respond adequately to tumor necrosis factor blockers or been unable to tolerate them, say researchers/show study results. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742580</comments>
            <pubDate>Sat, 29 Aug 2009 11:56:59 +0100</pubDate>
            <guid isPermaLink="false">2742580</guid>        </item>
        <item>
            <title>Ten common IL-22 polymorphisms not linked to psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2721529&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F84047%2FPsoriasis%2FTen_common_IL-22_polymorphisms_not_linked_to_psoriasis.html</link>
            <description>Researchers rule out common polymorphisms in the interleukin-22 gene as major risk factors for chronic plaque psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2721529</comments>
            <pubDate>Sat, 22 Aug 2009 10:15:44 +0100</pubDate>
            <guid isPermaLink="false">2721529</guid>        </item>
        <item>
            <title>Psoriasis patients say dermatologists need better communication skills</title>
            <link>http://www.medworm.com/index.php?rid=2697294&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83871%2FPsoriasis%2FPsoriasis_patients_say_dermatologists_need_better_communication_skills.html</link>
            <description>Survey findings indicate that dermatologists treating patients with psoriasis need to listen to their patients, use simple language and improve their psychological and interpersonal skills. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697294</comments>
            <pubDate>Fri, 14 Aug 2009 10:16:53 +0100</pubDate>
            <guid isPermaLink="false">2697294</guid>        </item>
        <item>
            <title>Biologic agent use in inflammatory diseases varies with age and gender</title>
            <link>http://www.medworm.com/index.php?rid=2697298&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83903%2FPsoriasis%2FBiologic_agent_use_in_inflammatory_diseases_varies_with_age_and_gender.html</link>
            <description>The average switch/stop rate for biologic therapy in older men with inflammatory diseases appears to be higher than that for younger men and for women, study findings suggest. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697298</comments>
            <pubDate>Fri, 14 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2697298</guid>        </item>
        <item>
            <title>Fish oils and climatotherapy promising alternative therapies for psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2697297&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83902%2FPsoriasis%2FFish_oils_and_climatotherapy_promising_alternative_therapies_for_psoriasis.html</link>
            <description>A review of randomised clinical trials shows that fish oils, climatotherapy and mind/body interventions are the most promising alternative therapies for psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697297</comments>
            <pubDate>Fri, 14 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2697297</guid>        </item>
        <item>
            <title>Switching to etanercept effective for psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=2697296&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83901%2FPsoriasis%2FSwitching_to_etanercept_effective_for_psoriasis_patients.html</link>
            <description>Etanercept is an effective treatment option for psoriasis in patients who have failed to respond to traditional and other biologic therapies, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697296</comments>
            <pubDate>Fri, 14 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2697296</guid>        </item>
        <item>
            <title>Cyclosporine and infliximab recommended for erythrodermic psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2697295&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83900%2FPsoriasis%2FCyclosporine_and_infliximab_recommended_for_erythrodermic_psoriasis.html</link>
            <description>The medical board for the National Psoriasis Foundation in the USA recommends the use of cyclosporine and infliximab as the fastest acting first-line agents in the treatment of erythrodermic psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697295</comments>
            <pubDate>Fri, 14 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2697295</guid>        </item>
        <item>
            <title>Psoriasis vulgaris linked to pro-atherogenic risk factors</title>
            <link>http://www.medworm.com/index.php?rid=2676024&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83766%2FPsoriasis%2FPsoriasis_vulgaris_linked_to_pro-atherogenic_risk_factors.html</link>
            <description>Psoriasis vulgaris is a pro-atherogenic condition, say researchers who found the condition was associated with dyslipidemia, inflammation, overweight and obesity. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2676024</comments>
            <pubDate>Fri, 07 Aug 2009 10:50:50 +0100</pubDate>
            <guid isPermaLink="false">2676024</guid>        </item>
        <item>
            <title>Stable form of galectin-9 shows therapeutic potential in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2679835&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83837%2FPsoriasis%2FStable_form_of_galectin-9_shows_therapeutic_potential_in_psoriasis.html</link>
            <description>Researchers have developed a stable form of galectin -9, which they say could be a useful therapeutic tool for the treatment of T-helper 1- and 17-mediated skin inflammation. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2679835</comments>
            <pubDate>Fri, 07 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2679835</guid>        </item>
        <item>
            <title>Anti-TNF-α associated psoriasiform lesions are new model of drug reaction</title>
            <link>http://www.medworm.com/index.php?rid=2676027&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83814%2FPsoriasis%2FAnti-TNF-%CE%B1_associated_psoriasiform_lesions_are_new_model_of_drug_reaction.html</link>
            <description>Psoriasiform eruptions that occur in association with anti-tumour necrosis factor-α therapy are a new model of drug reaction and differ from true psoriasis, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2676027</comments>
            <pubDate>Fri, 07 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2676027</guid>        </item>
        <item>
            <title>IGRAs superior for latent tuberculosis screening in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2676026&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83799%2FPsoriasis%2FIGRAs_superior_for_latent_tuberculosis_screening_in_psoriasis.html</link>
            <description>Study findings support the use of interferon-γ; release assays instead of the tuberculin skin test for identifying latent tuberculosis infection in psoriasis patients before they start antitumour necrosis factor-α therapy. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2676026</comments>
            <pubDate>Fri, 07 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2676026</guid>        </item>
        <item>
            <title>National Psoriasis Foundation advises on HIV-associated psoriasis treatment</title>
            <link>http://www.medworm.com/index.php?rid=2676025&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83782%2FPsoriasis%2FNational_Psoriasis_Foundation_advises_on_HIV-associated_psoriasis_treatment.html</link>
            <description>The Medical Board of the National Psoriasis Foundation in the USA has issued recommendations for the treatment of psoriasis in patients with HIV. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2676025</comments>
            <pubDate>Fri, 07 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2676025</guid>        </item>
        <item>
            <title>Streptococcal DNA triggers immune reaction in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2658929&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83728%2FPsoriasis%2FStreptococcal_DNA_triggers_immune_reaction_in_psoriasis.html</link>
            <description>Streptococcal antigen lacking nucleic acid decreases the proliferation of peripheral blood mononuclear cells and the activation of T cells in psoriasis patients, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2658929</comments>
            <pubDate>Sat, 01 Aug 2009 10:49:54 +0100</pubDate>
            <guid isPermaLink="false">2658929</guid>        </item>
        <item>
            <title>Itch and scratching predict UVB treatment efficacy</title>
            <link>http://www.medworm.com/index.php?rid=2655112&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83666%2FPsoriasis%2FItch_and_scratching_predict_UVB_treatment_efficacy.html</link>
            <description>Patients with higher levels of itch and scratching require more irradiation with ultraviolet B phototherapy to clear their psoriasis, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655112</comments>
            <pubDate>Fri, 31 Jul 2009 10:49:56 +0100</pubDate>
            <guid isPermaLink="false">2655112</guid>        </item>
        <item>
            <title>MRI helps psoriatic arthritis treatment decision making</title>
            <link>http://www.medworm.com/index.php?rid=2658931&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83730%2FPsoriasis%2FMRI_helps_psoriatic_arthritis_treatment_decision_making.html</link>
            <description>A whole-body magnetic resonance imaging scan in patients with psoriatic arthritis can provide more relevant information than a clinical exam alone, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2658931</comments>
            <pubDate>Fri, 31 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2658931</guid>        </item>
        <item>
            <title>Prevalence of coeliac disease increased in psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=2658930&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83729%2FPsoriasis%2FPrevalence_of_coeliac_disease_increased_in_psoriasis_patients.html</link>
            <description>The prevalence of coeliac disease is significantly higher in individuals with psoriasis than in healthy controls, research shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2658930</comments>
            <pubDate>Fri, 31 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2658930</guid>        </item>
        <item>
            <title>PRLE improves after methotrexate stopped</title>
            <link>http://www.medworm.com/index.php?rid=2655113&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83695%2FPsoriasis%2FPRLE_improves_after_methotrexate_stopped.html</link>
            <description>Posterior reversible leukoencephalopathy caused by chronic low-dose treatment with methotrexate is improved once the immunosuppressive therapy is stopped, a new case report shows. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655113</comments>
            <pubDate>Fri, 31 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655113</guid>        </item>
        <item>
            <title>Psoriasis inversely linked to contact allergy</title>
            <link>http://www.medworm.com/index.php?rid=2631751&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83587%2FPsoriasis%2FPsoriasis_inversely_linked_to_contact_allergy.html</link>
            <description>Researchers have found an inverse relationship between psoriasis and contact allergy, which they say suggests opposing immunological mechanisms for the two conditions. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2631751</comments>
            <pubDate>Fri, 24 Jul 2009 10:49:33 +0100</pubDate>
            <guid isPermaLink="false">2631751</guid>        </item>
        <item>
            <title>Factors for differentiating between psoriasis and ACD identified</title>
            <link>http://www.medworm.com/index.php?rid=2631755&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83601%2FPsoriasis%2FFactors_for_differentiating_between_psoriasis_and_ACD_identified.html</link>
            <description>Italian researchers have identified a histopathological parameter and a commercially available antibody that clinicians could use to help distinguish between psoriasis and allergic contact dermatitis of the palmo-plantar skin. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2631755</comments>
            <pubDate>Fri, 24 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2631755</guid>        </item>
        <item>
            <title>Tuberculosis immune responses impaired in untreated psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2631754&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83600%2FPsoriasis%2FTuberculosis_immune_responses_impaired_in_untreated_psoriasis.html</link>
            <description>Patients with severe untreated psoriasis appear to have decreased immune responses to Mycobacterium tuberculosis antigens, which could lead to false-negative results on tests for tuberculosis infection, study findings show. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2631754</comments>
            <pubDate>Fri, 24 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2631754</guid>        </item>
        <item>
            <title>Apolipoprotein E gene polymorphism implicated in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2631753&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83599%2FPsoriasis%2FApolipoprotein_E_gene_polymorphism_implicated_in_psoriasis.html</link>
            <description>Allele ε2 of the apolipoprotein E polymorphism may play a role in the development of psoriasis, particularly late-onset psoriasis, study results indicate. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2631753</comments>
            <pubDate>Fri, 24 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2631753</guid>        </item>
        <item>
            <title>Treatment guidelines change the way Germans treat psoriasis patients</title>
            <link>http://www.medworm.com/index.php?rid=2631752&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83598%2FPsoriasis%2FTreatment_guidelines_change_the_way_Germans_treat_psoriasis_patients.html</link>
            <description>Treatment guidelines are an important tool for improving the quality of care provided to patients with psoriasis, say German researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2631752</comments>
            <pubDate>Fri, 24 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2631752</guid>        </item>
        <item>
            <title>IL13 polymorphisms and smoking influence psoriatic arthritis development</title>
            <link>http://www.medworm.com/index.php?rid=2607538&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83454%2FPsoriasis%2FIL13_polymorphisms_and_smoking_influence_psoriatic_arthritis_development.html</link>
            <description>Polymorphisms in the gene encoding interleukin 13 appear to be more strongly associated with psoriatic arthritis than with cutaneous psoriasis alone, researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2607538</comments>
            <pubDate>Fri, 17 Jul 2009 10:48:49 +0100</pubDate>
            <guid isPermaLink="false">2607538</guid>        </item>
        <item>
            <title>Focused UV-B microphototherapy limits psoriasis irradiation</title>
            <link>http://www.medworm.com/index.php?rid=2612251&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83530%2FPsoriasis%2FFocused_UV-B_microphototherapy_limits_psoriasis_irradiation.html</link>
            <description>A newly developed ultraviolet-B narrowband microphototherapy that uses an optical fibre to direct irradiation directly on to psoriatic patches is a simple and particularly efficient treatment for plaque psoriasis, say researchers. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612251</comments>
            <pubDate>Fri, 17 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2612251</guid>        </item>
        <item>
            <title>UV doses during climate therapy for psoriasis exceed prescribed doses</title>
            <link>http://www.medworm.com/index.php?rid=2612250&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83529%2FPsoriasis%2FUV_doses_during_climate_therapy_for_psoriasis_exceed_prescribed_doses.html</link>
            <description>Psoriasis patients using climate therapy to clear their skin condition may be exposing themselves to greater ultraviolet doses than would normally be prescribed, researchers have found. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2612250</comments>
            <pubDate>Fri, 17 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2612250</guid>        </item>
        <item>
            <title>Quality of life scale specific to nail psoriasis developed</title>
            <link>http://www.medworm.com/index.php?rid=2607540&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83496%2FPsoriasis%2FQuality_of_life_scale_specific_to_nail_psoriasis_developed.html</link>
            <description>Researchers have developed a scale that is effective for measuring quality of life in patients with nail psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2607540</comments>
            <pubDate>Fri, 17 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2607540</guid>        </item>
        <item>
            <title>Itch has serious impact for patients with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2607539&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83479%2FPsoriasis%2FItch_has_serious_impact_for_patients_with_psoriasis.html</link>
            <description>Itch appears to be one of the most important symptoms of psoriasis, as rated by clinicians and patients in a qualitative study. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2607539</comments>
            <pubDate>Fri, 17 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2607539</guid>        </item>
        <item>
            <title>Six candidate genes implicated in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2585754&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83371%2FPsoriasis%2FSix_candidate_genes_implicated_in_psoriasis.html</link>
            <description>Research supports the involvement of six candidate genes in susceptibility to psoriasis, some of which are already implicated in the aetiology of other skin and immune-mediated disorders. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2585754</comments>
            <pubDate>Fri, 10 Jul 2009 10:49:33 +0100</pubDate>
            <guid isPermaLink="false">2585754</guid>        </item>
        <item>
            <title>Nocardiosis a potentially fatal complication of anti-TNF-α therapy</title>
            <link>http://www.medworm.com/index.php?rid=2589538&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83432%2FPsoriasis%2FNocardiosis_a_potentially_fatal_complication_of_anti-TNF-%CE%B1_therapy.html</link>
            <description>Disseminated nocardiosis is a rare but potentially fatal complication of treatment with tumour necrosis factor -α blockers used in the management of psoriasis. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589538</comments>
            <pubDate>Fri, 10 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2589538</guid>        </item>
        <item>
            <title>Tuberculosis risk with anti-TNF drugs varies by agent</title>
            <link>http://www.medworm.com/index.php?rid=2589537&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83431%2FPsoriasis%2FTuberculosis_risk_with_anti-TNF_drugs_varies_by_agent.html</link>
            <description>The risk of tuberculosis associated with anti-tumour necrosis factor therapy is greater with infliximab and adalimumab than with etanercept, French researchers report. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589537</comments>
            <pubDate>Fri, 10 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2589537</guid>        </item>
        <item>
            <title>Adalimumab shows promise in etanercept nonresponders</title>
            <link>http://www.medworm.com/index.php?rid=2585756&amp;cid=s_36322_12_f&amp;fid=36322&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F60%2F83407%2FPsoriasis%2FAdalimumab_shows_promise_in_etanercept_nonresponders.html</link>
            <description>Adalimumab may be a useful second-line treatment in patients with psoriasis who fail to respond to etanercept, an open-label study has found. (Source: MedWire News - Psoriasis)</description>
            <author>MedWire News - Psoriasis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2585756</comments>
            <pubDate>Fri, 10 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2585756</guid>        </item>
    </channel>
</rss>

